Oxidative Stress Contributes to Inflammatory and Cellular Damage in Systemic Lupus Erythematosus: Cellular Markers and Molecular Mechanism

References

• Pannu N, Bhatnagar A. Oxidative stress and immune complexes: pathogenic mechanisms in pristane induced murine model of lupus. Immunobiology. 2020;225(1):151871. doi:10.1016/j.imbio.2019.11.006
   Web of Science ®Google Scholar
• Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG. Oxidative stress in autoimmune rheumatic diseases. Free Radic Biol Med. 2018;125:3–14. doi:10.1016/j.freeradbiomed.2018.05.086
   PubMed Web of Science ®Google Scholar
• Fujii J, Kurahashi T, Konno T, Homma T, Iuchi Y. Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus. World J Nephrol. 2015;4(2):213–222. doi:10.5527/wjn.v4.i2.213
   PubMedGoogle Scholar
• Duarte-Delgado NP, Cala MP, Barreto A, Rodriguez CL. Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus. J Transl Autoimmun. 2022;5:100150. doi:10.1016/j.jtauto.2022.100150
   Google Scholar
• Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131(3):398–404. doi:10.1046/j.1365-2249.2003.02104.x
   PubMed Web of Science ®Google Scholar
• Wojcik P, Gegotek A, Zarkovic N, Skrzydlewska E. Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases. Int J Mol Sci. 2021;22(2):723. doi:10.3390/ijms22020723
   Web of Science ®Google Scholar
• Ahmad R, Ahsan H. Singlet oxygen species and systemic lupus erythematosus: a brief review. J Immunoassay Immunochem. 2019;40(4):343–349. doi:10.1080/15321819.2019.1616555
   PubMedGoogle Scholar
• Shruthi S, Thabah MM, Zachariah B, Negi VS. Association of oxidative stress with disease activity and damage in systemic lupus erythematosus: a cross sectional study from a tertiary care centre in Southern India. Indian J Clin Biochem. 2021;36(2):185–193. doi:10.1007/s12291-020-00879-5
   PubMed Web of Science ®Google Scholar
• Wang S, Liu Y, Liu J, et al. Mitochondria-derived methylmalonic acid, a surrogate biomarker of mitochondrial dysfunction and oxidative stress, predicts all-cause and cardiovascular mortality in the general population. Redox Biol. 2020;37:101741. doi:10.1016/j.redox.2020.101741
   PubMed Web of Science ®Google Scholar
• Costa JH, Mohanapriya G, Bharadwaj R, et al. ROS/RNS balancing, aerobic fermentation regulation and cell cycle control - a complex early trait (‘CoV-MAC-TED’) for combating SARS-CoV-2-induced cell reprogramming. Front Immunol. 2021;12:673692. doi:10.3389/fimmu.2021.673692
   Web of Science ®Google Scholar
• Zhang VX, Sze KM, Chan LK, et al. Antioxidant supplements promote tumor formation and growth and confer drug resistance in hepatocellular carcinoma by reducing intracellular ROS and induction of TMBIM1. Cell Biosci. 2021;11(1):217. doi:10.1186/s13578-021-00731-0
   Web of Science ®Google Scholar
• Hu C, Zhang J, Hong S, et al. Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus. Free Radic Biol Med. 2021;163:210–219. doi:10.1016/j.freeradbiomed.2020.12.006
   PubMed Web of Science ®Google Scholar
• Wang L, Law HKW. Immune complexes impaired glomerular endothelial cell functions in lupus nephritis. Int J Mol Sci. 2019;20(21):5281. doi:10.3390/ijms20215281
   Web of Science ®Google Scholar
• Nabatian-Asl M, Ghorbanihaghjo A, Malek Mahdavi A, Khabbazi A, Hajialilo M, Ghojazadeh M. Effects of melatonin supplementation on serum oxidative stress markers and disease activity in systemic lupus erythematosus patients: a randomised, double-blind, placebo-controlled trial. Int J Clin Pract. 2021;75(7):e14246. doi:10.1111/ijcp.14246
   Web of Science ®Google Scholar
• Ene CD, Georgescu SR, Tampa M, et al. Cellular response against oxidative stress, a novel insight into lupus nephritis pathogenesis. J Pers Med. 2021;11(8):693. doi:10.3390/jpm11080693
   Web of Science ®Google Scholar
• Fortner KA, Blanco LP, Buskiewicz I, et al. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci Med. 2020;7(1):e000387. doi:10.1136/lupus-2020-000387
   PubMed Web of Science ®Google Scholar
• Ramalingam A, Budin SB, Mohd Fauzi N, Ritchie RH, Zainalabidin S. Targeting mitochondrial reactive oxygen species-mediated oxidative stress attenuates nicotine-induced cardiac remodeling and dysfunction. Sci Rep. 2021;11(1):13845. doi:10.1038/s41598-021-93234-4
   Web of Science ®Google Scholar
• Nazim UM, Yin H, Park SY. Autophagy flux inhibition mediated by celastrol sensitized lung cancer cells to TRAILinduced apoptosis via regulation of mitochondrial transmembrane potential and reactive oxygen species. Mol Med Rep. 2019;19(2):984–993. doi:10.3892/mmr.2018.9757
   Web of Science ®Google Scholar
• Lee HT, Wu TH, Lin CS, et al. The pathogenesis of systemic lupus erythematosus - From the viewpoint of oxidative stress and mitochondrial dysfunction. Mitochondrion. 2016;30:1–7. doi:10.1016/j.mito.2016.05.007
   PubMed Web of Science ®Google Scholar
• Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12(3):169–182. doi:10.1038/nrrheum.2015.172
   PubMed Web of Science ®Google Scholar
• Liu J, Ming S, Song W, et al. B and T lymphocyte attenuator regulates autophagy in mycobacterial infection via the AKT/mTOR signal pathway. Int Immunopharmacol. 2021;91:107215. doi:10.1016/j.intimp.2020.107215
   PubMed Web of Science ®Google Scholar
• Zhang JC, Chen G, Chen L, et al. TGF-beta/BAMBI pathway dysfunction contributes to peripheral Th17/Treg imbalance in chronic obstructive pulmonary disease. Sci Rep. 2016;6:31911. doi:10.1038/srep31911
   PubMed Web of Science ®Google Scholar
• Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101(3):1371–1426. doi:10.1152/physrev.00026.2020
   PubMed Web of Science ®Google Scholar
• Shi H, Chapman NM, Wen J, et al. Amino acids license kinase mTORC1 activity and Treg cell function via small G proteins Rag and Rheb. Immunity. 2019;51(6):1012–27e7. doi:10.1016/j.immuni.2019.10.001
   Web of Science ®Google Scholar
• Oaks Z, Winans T, Huang N, Banki K, Perl A. Activation of the mechanistic target of rapamycin in SLE: explosion of evidence in the last five years. Curr Rheumatol Rep. 2016;18(12):73. doi:10.1007/s11926-016-0622-8
   PubMed Web of Science ®Google Scholar
• Peixoto TV, Carrasco S, Botte DAC, et al. CD4(+)CD69(+) T cells and CD4(+)CD25(+)FoxP3(+) Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice. Adv Rheumatol. 2019;59(1):30. doi:10.1186/s42358-019-0072-x
   PubMedGoogle Scholar
• Sahni A, Narra HP, Sahni SK. Activation of mechanistic target of rapamycin (mTOR) in human endothelial cells infected with pathogenic spotted fever group rickettsiae. Int J Mol Sci. 2020;21(19):7179. doi:10.3390/ijms21197179
   Web of Science ®Google Scholar
• Braga A, Neves E, Guimaraes J, Braga J, Vasconcelos C. The dynamics of Th17 / Treg ratio in SLE patients during pregnancy. J Reprod Immunol. 2022;151:103622. doi:10.1016/j.jri.2022.103622
   Web of Science ®Google Scholar
• He J, Ma J, Ren B, Liu A. Advances in systemic lupus erythematosus pathogenesis via mTOR signaling pathway. Semin Arthritis Rheum. 2020;50(2):314–320. doi:10.1016/j.semarthrit.2019.09.022
   Web of Science ®Google Scholar
• He S, Xue M, Cai G. IL-6 alters migration capacity of CD4(+)Foxp3(+) regulatory T cells in systemic lupus erythematosus. Scand J Immunol. 2021;94(5):e13099. doi:10.1111/sji.13099
   Web of Science ®Google Scholar
• Zhang X, Lindwall E, Gauthier C, et al. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production. Lupus. 2015;24(9):909–917. doi:10.1177/0961203314567750
   PubMed Web of Science ®Google Scholar
• Gigante A, Iannazzo F, Navarini L, et al. Metabolic syndrome and adipokine levels in systemic lupus erythematosus and systemic sclerosis. Clin Rheumatol. 2021;40(10):4253–4258. doi:10.1007/s10067-021-05731-6
   Web of Science ®Google Scholar
• Yang J, Yang X, Zou H, Li M. Oxidative stress and Treg and Th17 dysfunction in systemic lupus erythematosus. Oxid Med Cell Longev. 2016;2016:2526174. doi:10.1155/2016/2526174
   PubMed Web of Science ®Google Scholar
• Shan J, Jin H, Xu Y. T Cell Metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus. Front Immunol. 2020;11:1027. doi:10.3389/fimmu.2020.01027
   PubMed Web of Science ®Google Scholar
• Yu H, Jiang L, Liu R, et al. Association between the ratio of aryl hydrocarbon receptor (AhR) in Th17 cells to AhR in Treg cells and SLE skin lesions. Int Immunopharmacol. 2019;69:257–262. doi:10.1016/j.intimp.2019.01.039
   PubMed Web of Science ®Google Scholar
• de Araujo EF, Feriotti C, Galdino NAL, Preite NW, Calich VLG, Loures FV. The IDO-AhR axis controls Th17/Treg immunity in a pulmonary model of fungal infection. Front Immunol. 2017;8:880. doi:10.3389/fimmu.2017.00880
   PubMed Web of Science ®Google Scholar
• Mockel T, Basta F, Weinmann-Menke J, Schwarting A. B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE). Autoimmun Rev. 2021;20(2):102736. doi:10.1016/j.autrev.2020.102736
   Web of Science ®Google Scholar
• Stohl W, Yu N, Chalmers S, Putterman C, Jacob CO. Development of murine systemic lupus erythematosus in the absence of BAFF. Arthritis Rheumatol. 2020;72(2):292–302. doi:10.1002/art.41097
   Web of Science ®Google Scholar
• Wilson CS, Stocks BT, Hoopes EM, et al. Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice. JCI Insight. 2021;6(19):e143245. doi:10.1172/jci.insight.143245
   Web of Science ®Google Scholar
• Pathak S, Kumar KR, Kanta H, et al. Fatty acid amide hydrolase regulates peripheral B cell receptor revision, polyreactivity, and B1 cells in lupus. J Immunol. 2016;196(4):1507–1516. doi:10.4049/jimmunol.1500291
   Web of Science ®Google Scholar
• Dong GF, Zhang X, He DN, Li L, Zhang GF. Effect of leflunomide on the abnormal expression of lipid rafts and F-actin in B lymphocytes from patients with systemic lupus erythematosus. J Immunol Res. 2015;2015:832916. doi:10.1155/2015/832916
   Web of Science ®Google Scholar
• Azzouz D, Khan MA, Palaniyar N. ROS induces NETosis by oxidizing DNA and initiating DNA repair. Cell Death Discov. 2021;7(1):113. doi:10.1038/s41420-021-00491-3
   PubMed Web of Science ®Google Scholar
• Breitenstein MK, Hu VJ, Bhatnagar R, Ratnagiri M. Approaching neural net feature interpretation using stacked autoencoders: gene expression profiling of systemic lupus erythematosus patients. AMIA Jt Summits Transl Sci Proc. 2019;2019:435–442.
   Google Scholar
• Campbell AM, Kashgarian M, Shlomchik MJ. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci Transl Med. 2012;4(157):157ra41. doi:10.1126/scitranslmed.3004801
   Web of Science ®Google Scholar
• El-Ghoneimy DH, Hesham M, Hasan R, Tarif M, Gouda S. The behavior of neutrophil extracellular traps and NADPH oxidative activity in pediatric systemic lupus erythematosus: relation to disease activity and lupus nephritis. Clin Rheumatol. 2019;38(9):2585–2593. doi:10.1007/s10067-019-04547-9
   Web of Science ®Google Scholar
• Bao Y, Ledderose C, Graf AF, et al. mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis. J Cell Biol. 2015;210(7):1153–1164. doi:10.1083/jcb.201503066
   PubMed Web of Science ®Google Scholar
• Lightfoot YL, Blanco LP, Kaplan MJ. Metabolic abnormalities and oxidative stress in lupus. Curr Opin Rheumatol. 2017;29(5):442–449. doi:10.1097/BOR.0000000000000413
   PubMed Web of Science ®Google Scholar
• Bona N, Pezzarini E, Balbi B, et al. Oxidative stress, inflammation and disease activity biomarkers in lupus nephropathy. Lupus. 2020;29(3):311–323. doi:10.1177/0961203320904784
   PubMed Web of Science ®Google Scholar
• Granick M, Leuin AS, Trepanier LA. Plasma and urinary F2-isoprostane markers of oxidative stress are increased in cats with early (stage 1) chronic kidney disease. J Feline Med Surg. 2021;23(8):692–699. doi:10.1177/1098612X20969358
   Web of Science ®Google Scholar
• Krata N, Foroncewicz B, Zagozdzon R, et al. Peroxiredoxins as markers of oxidative stress in IgA nephropathy, membranous nephropathy and lupus nephritis. Arch Immunol Ther Exp (Warsz). 2021;70(1):3. doi:10.1007/s00005-021-00638-1
   Web of Science ®Google Scholar
• Zavadskiy S, Sologova S, Moldogazieva N. Oxidative distress in aging and age-related diseases: spatiotemporal dysregulation of protein oxidation and degradation. Biochimie. 2022;195:114–134. doi:10.1016/j.biochi.2021.12.002
   Google Scholar
• Song YR, Kim JK, Lee HS, Kim SG, Choi EK. Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients. BMC Nephrol. 2020;21(1):281. doi:10.1186/s12882-020-01937-z
   Web of Science ®Google Scholar
• Ahsan H. 3-Nitrotyrosine: a biomarker of nitrogen free radical species modified proteins in systemic autoimmunogenic conditions. Hum Immunol. 2013;74(10):1392–1399. doi:10.1016/j.humimm.2013.06.009
   PubMed Web of Science ®Google Scholar
• Ren W, Liu G, Yin J, et al. Amino-acid transporters in T-cell activation and differentiation. Cell Death Dis. 2017;8(3):e2655. doi:10.1038/cddis.2016.222
   Google Scholar
• Liu T, Han J, Zhang R, et al. Characteristics of purified anti-beta2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome. Rheumatology (Oxford). 2022;61(3):1243–1254. doi:10.1093/rheumatology/keab416
   Web of Science ®Google Scholar
• Peluso M, Russo V, Mello T, Galli A. Oxidative stress and DNA damage in chronic disease and environmental studies. Int J Mol Sci. 2020;21(18):6936. doi:10.3390/ijms21186936
   Web of Science ®Google Scholar
• Ntouros PA, Vlachogiannis NI, Pappa M, et al. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus systemic lupus erythematosus. Clin Immunol. 2021;229:108765. doi:10.1016/j.clim.2021.108765
   PubMed Web of Science ®Google Scholar
• Tumurkhuu G, Chen S, Montano EN, et al. Oxidative DNA damage accelerates skin inflammation in pristane-induced lupus model. Front Immunol. 2020;11:554725. doi:10.3389/fimmu.2020.554725
   PubMed Web of Science ®Google Scholar
• Ene CD, Penescu MN, Georgescu SR, Tampa M, Nicolae I. Posttranslational modifications pattern in clear cell renal cell carcinoma. Metabolites. 2020;11(1):10. doi:10.3390/metabo11010010
   Web of Science ®Google Scholar
• Ray D, Strickland FM, Richardson BC. Oxidative stress and dietary micronutrient deficiencies contribute to overexpression of epigenetically regulated genes by lupus T cells. Clin Immunol. 2018;196:97–102. doi:10.1016/j.clim.2018.04.003
   PubMed Web of Science ®Google Scholar
• Gorelik GJ, Yarlagadda S, Patel DR, Richardson BC. Protein kinase Cdelta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum. 2012;64(9):2964–2974. doi:10.1002/art.34503
   Google Scholar
• Richardson B, Strickland FM, Sawalha AH, Gorelik G. Protein kinase Cdelta mutations may contribute to lupus through effects on T cells: comment on the article by Belot et al. Arthritis Rheumatol. 2014;66(1):228–229. doi:10.1002/art.38235
   Web of Science ®Google Scholar
• He XJ, Ding Y, Xiang W, Dang XQ. Roles of 1,25(OH)2D3 and vitamin D receptor in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus by regulating the activation of CD4+ T cells and the PKCdelta/ERK signaling pathway. Cell Physiol Biochem. 2016;40(3–4):743–756. doi:10.1159/000453135
   Google Scholar
• Zhang CX, Wang HY, Yin L, Mao YY, Zhou W. Immunometabolism in the pathogenesis of systemic lupus erythematosus. J Transl Autoimmun. 2020;3:100046. doi:10.1016/j.jtauto.2020.100046
   PubMedGoogle Scholar
• Bethunaickan R, Sahu R, Liu Z, et al. Anti-tumor necrosis factor alpha treatment of interferon-alpha-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Arthritis Rheum. 2012;64(10):3399–3408. doi:10.1002/art.34553
   PubMed Web of Science ®Google Scholar
• Tian Y, Guo H, Miao X, et al. Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis. 2020;11(5):319. doi:10.1038/s41419-020-2547-4
   PubMed Web of Science ®Google Scholar
• Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol. 2013;9(11):674–686. doi:10.1038/nrrheum.2013.147
   PubMed Web of Science ®Google Scholar
• Akiyama M, Kaneko Y, Takeuchi T. Lupus aortitis: a fatal, inflammatory cardiovascular complication in systemic lupus erythematosus. Lupus. 2020;29(12):1652–1654. doi:10.1177/0961203320950017
   Web of Science ®Google Scholar
• Martin N, Tu X, Egan AJ, Stover C. Complement activation on endothelial cell-derived microparticles-A key determinant for cardiovascular risk in patients with systemic lupus erythematosus? Medicina. 2020;56(10):533. doi:10.3390/medicina56100533
   Google Scholar
• Giannelou M, Mavragani CP. Cardiovascular disease in systemic lupus erythematosus: a comprehensive update. J Autoimmun. 2017;82:1–12. doi:10.1016/j.jaut.2017.05.008
   PubMed Web of Science ®Google Scholar
• Lopez-Pedrera C, Barbarroja N, Jimenez-Gomez Y, Collantes-Estevez E, Aguirre MA, Cuadrado MJ. Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches. Rheumatology. 2016;55(12):2096–2108. doi:10.1093/rheumatology/kew054
   Web of Science ®Google Scholar
• Lozovoy MA, Simao AN, Morimoto HK, et al. Hypertension is associated with serologically active disease in patients with systemic lupus erythematosus: role of increased Th1/Th2 ratio and oxidative stress. Scand J Rheumatol. 2014;43(1):59–62. doi:10.3109/03009742.2013.834963
   PubMed Web of Science ®Google Scholar
• Russell-Goldman E, Nazarian RM. Subacute cutaneous lupus erythematosus with positive anti-Ro antibodies following palbociclib and letrozole treatment: a case report and literature review. J Cutan Pathol. 2020;47(7):654–658. doi:10.1111/cup.13673
   Web of Science ®Google Scholar
• Lozovoy MA, Simao AN, Panis C, et al. Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus. Lupus. 2011;20(12):1250–1259. doi:10.1177/0961203311411350
   Web of Science ®Google Scholar
• Wu T, Ye Y, Min SY, et al. Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid. Arthritis Rheumatol. 2014;66(11):3129–3139. doi:10.1002/art.38782
   PubMed Web of Science ®Google Scholar
• Lai ZW, Hanczko R, Bonilla E, et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2012;64(9):2937–2946. doi:10.1002/art.34502
   PubMed Web of Science ®Google Scholar
• Tan MKX, Heng TYJ, Mak A. The potential use of metformin, dipyridamole, N-Acetylcysteine and statins as adjunctive therapy for systemic lupus erythematosus. Cells. 2019;8(4):323. doi:10.3390/cells8040323
   Web of Science ®Google Scholar
• Monaco A, Ferrandino I, Boscaino F, et al. Conjugated linoleic acid prevents age-dependent neurodegeneration in a mouse model of neuropsychiatric lupus via the activation of an adaptive response. J Lipid Res. 2018;59(1):48–57. doi:10.1194/jlr.M079400
   PubMed Web of Science ®Google Scholar
• Bergamo P, Maurano F, Rossi M. Phase 2 enzyme induction by conjugated linoleic acid improves lupus-associated oxidative stress. Free Radic Biol Med. 2007;43(1):71–79. doi:10.1016/j.freeradbiomed.2007.03.023
   PubMed Web of Science ®Google Scholar
• Oaks Z, Winans T, Caza T, et al. Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice. Arthritis Rheumatol. 2016;68(11):2728–2739. doi:10.1002/art.39791
   PubMed Web of Science ®Google Scholar
• Lai ZW, Borsuk R, Shadakshari A, et al. Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. J Immunol. 2013;191(5):2236–2246. doi:10.4049/jimmunol.1301005
   PubMed Web of Science ®Google Scholar
• Buskiewicz IA, Montgomery T, Yasewicz EC, et al. Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci Signal. 2016;9(456):ra115. doi:10.1126/scisignal.aaf1933
   PubMed Web of Science ®Google Scholar
• Lopez-Pedrera C, Villalba JM, Patino-Trives AM, et al. Therapeutic potential and immunomodulatory role of coenzyme Q(10) and its analogues in systemic autoimmune diseases. Antioxidants. 2021;10(4):600. doi:10.3390/antiox10040600
   Web of Science ®Google Scholar
• Blanco LP, Pedersen HL, Wang X, et al. Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone. Arthritis Rheumatol. 2020;72(3):454–464. doi:10.1002/art.41128
   PubMed Web of Science ®Google Scholar
• Lin M, Li L, Zhang Y, et al. Baicalin ameliorates H2O2 induced cytotoxicity in HK-2 cells through the inhibition of ER stress and the activation of Nrf2 signaling. Int J Mol Sci. 2014;15(7):12507–12522. doi:10.3390/ijms150712507
   Web of Science ®Google Scholar
• Ding H, Wang H, Zhao Y, Sun D, Zhai X. Protective effects of baicalin on Abeta(1)(-)(4)(2)-induced learning and memory deficit, oxidative stress, and apoptosis in rat. Cell Mol Neurobiol. 2015;35(5):623–632. doi:10.1007/s10571-015-0156-z
   Web of Science ®Google Scholar
• Park D, Jeong H, Lee MN, et al. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci Rep. 2016;6:21772. doi:10.1038/srep21772
   PubMed Web of Science ®Google Scholar
• Tsai PY, Ka SM, Chang JM, et al. Antroquinonol differentially modulates T cell activity and reduces interleukin-18 production, but enhances Nrf2 activation, in murine accelerated severe lupus nephritis. Arthritis Rheum. 2012;64(1):232–242. doi:10.1002/art.33328
   Google Scholar
• Tsai PY, Ka SM, Chang JM, et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med. 2011;51(3):744–754. doi:10.1016/j.freeradbiomed.2011.05.016
   PubMed Web of Science ®Google Scholar
• Fouad H, Yahia S, Elsaid A, et al. Oxidative stress and vitamin D receptor BsmI gene polymorphism in Egyptian children with systemic lupus erythematosus: a single center study. Lupus. 2019;28(6):771–777. doi:10.1177/0961203319846380
   Web of Science ®Google Scholar
• Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol. 2010;172(2):205–216. doi:10.1093/aje/kwq089
   Web of Science ®Google Scholar
• Sporn MB, Liby KT, Yore MM, Fu L, Lopchuk JM, Gribble GW. New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress. J Nat Prod. 2011;74(3):537–545. doi:10.1021/np100826q
   PubMed Web of Science ®Google Scholar
• Pagano G, Castello G, Pallardo FV. Sjogren’s syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials. Free Radic Res. 2013;47(2):71–73. doi:10.3109/10715762.2012.748904
   PubMed Web of Science ®Google Scholar
• Tobore TO. Oxidative/nitroxidative stress and multiple sclerosis. J Mol Neurosci. 2021;71(3):506–514. doi:10.1007/s12031-020-01672-y
   Web of Science ®Google Scholar
• Yevgi R, Demir R. Oxidative stress activity of fingolimod in multiple sclerosis. Clin Neurol Neurosurg. 2021;202:106500. doi:10.1016/j.clineuro.2021.106500
   Web of Science ®Google Scholar